Source:http://linkedlifedata.com/resource/pubmed/id/18278811
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2008-4-10
|
pubmed:abstractText |
New therapeutic strategies are needed to improve treatment outcomes in men with hormone-refractory prostate cancer. A better understanding of the molecular mechanisms of cell death in response to therapeutic strategies will help avoid ineffective treatment regimens and provide a molecular basis for new therapeutic modalities targeting apoptosis-resistant forms of prostate cancer. In this review, the authors focused on the established aberrations of apoptosis in hormone-refractory prostate cancer, and they have described novel treatment strategies to overcome apoptosis resistance.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
112
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1660-71
|
pubmed:meshHeading |
pubmed-meshheading:18278811-Antineoplastic Agents, Hormonal,
pubmed-meshheading:18278811-Apoptosis,
pubmed-meshheading:18278811-Apoptosis Regulatory Proteins,
pubmed-meshheading:18278811-Cell Death,
pubmed-meshheading:18278811-Drug Resistance, Neoplasm,
pubmed-meshheading:18278811-Humans,
pubmed-meshheading:18278811-Male,
pubmed-meshheading:18278811-Prostatic Neoplasms,
pubmed-meshheading:18278811-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Mechanisms of apoptosis resistance and treatment strategies to overcome them in hormone-refractory prostate cancer.
|
pubmed:affiliation |
Division of Urology, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, N.I.H., Extramural
|